DZ BANK AG analyst Sven Olaf Kuerten maintained a Sell rating on Qiagen (QGEN) today. The company’s shares closed last Monday at $51.92, close to its 52-week high of $55.27.
Kuerten has an average return of 2.8% when recommending Qiagen.
According to TipRanks.com, Kuerten is ranked #6581 out of 7142 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Qiagen with a $57.15 average price target, representing a 9.8% upside. In a report issued on December 10, Independent Research also maintained a Sell rating on the stock with a EUR36.00 price target.
See today’s analyst top recommended stocks >>
Qiagen’s market cap is currently $11.88B and has a P/E ratio of 63.20. The company has a Price to Book ratio of -31.93.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
